Sign in
4

Changes in Ownership

AEON Biopharma, Inc. Filed Acc 0001104659-23-083566

Options or other derivatives

  • Chief Executive Officer acquired 2,441,394 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Forth Marc · Chief Executive Officer

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2023-07-21 Grant or award : show line 1 in the form Stock Option +970,588 970,588 D
2023-07-21 Grant or award : show line 2 in the form Stock Option +324,021 324,021 D
2023-07-21 Grant or award : show line 3 in the form Stock Option +291,332 291,332 D
2023-07-21 Grant or award : show line 4 in the form Stock Option +381,480 381,480 D
2023-07-21 Grant or award : show line 5 in the form Stock Option +194,118 194,118 D
2023-07-21 Grant or award : show line 6 in the form Restricted Stock Units +279,855 279,855 D
Loading xslF345X05/tm2321918-9_4seq1.xml…